, a consulting firm that works with pharmaceutical and biotech firms, is expanding its management team with the post of practice head.
Filling the new role is Thomas Colatsky. He will focus on drug discovery, drug candidate development and management of early-stage ventures.
Colatsky has more than 30 years of experience in the life science industry. His most recent positions were as vice president and chief science officer at Icoria and vice president of cardiovascular and metabolic disorders at Wyeth Pharmaceuticals. Colatsky received his Ph.D. in physiology from the State University of New York at Buffalo.
Copyright 2024 by Capitol Broadcasting Company. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
